Nowadays, the therapeutic approach for genetic diseases based on the rescue of defective phenotypes of pathogenic mutants by pharmacological chaperones is considered one of the most promising strategies, particularly for NDI [80]. The gene discussed is AVPR2; the disease is hereditary disease.